[Federal Register Volume 83, Number 91 (Thursday, May 10, 2018)]
[Notices]
[Pages 21785-21786]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-09947]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held of the National Vaccine Advisory 
Committee (NVAC). The meeting will be open to the public via 
teleconference; a public comment session will be held during the 
meeting.

DATES: The meeting will be held on June 25, 2018, from 2:00 p.m. to 
4:30 p.m. EST. The confirmed meeting times and agenda will be posted on 
the NVAC website at http://www.hhs.gov/nvpo/nvac/meetings/index.html as 
soon as they become available.

ADDRESSES: Instructions regarding attending this meeting will be posted 
one week prior to the meeting at: http://www.hhs.gov/nvpo/nvac/meetings/index.html. Pre-registration is required for members of the 
public who wish to attend the meeting and who wish to participate in 
the public comment session. Individuals who wish to attend the meeting 
and/or participate in the public comment session should register at 
http://www.hhs.gov/nvpo/nvac/meetings/index.html.

FOR FURTHER INFORMATION CONTACT: Captain Angela Shen, National Vaccine 
Program Office, U.S. Department of Health and Human Services, Room 
715H, Hubert H. Humphrey Building, 200 Independence Avenue SW, 
Washington, DC 20201. Phone: (202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was 
mandated to establish the National Vaccine Program to achieve optimal 
prevention of human infectious diseases through immunization and to 
achieve optimal prevention against adverse reactions to vaccines. The 
NVAC was established to provide advice and make recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program's responsibilities. The Assistant Secretary for Health serves 
as Director of the National Vaccine Program.
    The public meeting will include a presentation from the HPV 
Implementation Working Group on its findings and draft recommendations 
for strengthening the effectiveness of national, state, and local 
efforts to improve HPV coverage rates. The presentation will be 
followed by Committee deliberation and a vote. The public meeting will 
also include a presentation on the recent HHS report, ``Encouraging 
Vaccine Innovation: Promoting the Development of Vaccines that Minimize 
the Burden of Infectious Diseases in the 21st Century,'' which was 
submitted to Congress in accordance with provisions in the 21st Century 
Cures Act. All agenda items are tentative and subject to change. 
Information on the final meeting agenda will be posted prior to the 
meeting on the NVAC website: http://www.hhs.gov/nvpo/nvac/index.html.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office ([email protected]) at least five 
business days prior to the meeting.


[[Page 21786]]


    Dated: May 7, 2018.
Roula Sweis,
Deputy Director, National Vaccine Program Office.
[FR Doc. 2018-09947 Filed 5-9-18; 8:45 am]
 BILLING CODE 4150-44-P